Cancer fatigue is more than ordinary tiredness. It may persist despite sleep, make thinking difficult and turn familiar tasks into enormous efforts. If you are considering another supplement, start with a more useful question: what is contributing to the fatigue, and which problems can be addressed?
The evidence, briefly
Cancer-related fatigue is common during treatment and can continue afterward. It is often multifactorial: cancer and its treatments may contribute alongside anemia, infection, low food or fluid intake, pain, poor sleep, emotional distress and other medical conditions. Finding one factor does not guarantee that treating it will resolve everything. The National Cancer Institute (NCI) emphasizes assessment of contributing causes rather than treating all fatigue as the same problem.
For symptom management, a 2024 ASCO–Society for Integrative Oncology guideline evaluated evidence from 113 randomized clinical trials. Exercise tailored to the person, cognitive behavioral therapy (CBT), and mindfulness-based programs have the most consistent guideline support across treatment and survivorship. These interventions help some people; none is a cure-all, and the certainty of evidence varies by intervention.
First, describe the pattern
A short conversation can reveal more than simply reporting “I am exhausted.” Tell the care team when the fatigue started, whether it worsened suddenly or gradually, whether it follows infusion or radiation days, how you are sleeping and eating, and what activities are now difficult. Consider noting fatigue on a 0–10 scale along with sleep, appetite, activity, dizziness, breathlessness and any new symptoms for several days.
Depending on symptoms, treatment and examination, a clinician may review blood counts, medications, hydration and nutrition, sleep problems, pain, mood or other tests. There is no universal laboratory panel for every person with fatigue. Iron or vitamin supplements are not a substitute for diagnosing a deficiency.
Five areas worth checking
- Anemia or blood loss. Low red blood cell counts can contribute to weakness, shortness of breath and fatigue. The cause and severity determine whether treatment is needed.
- Food, fluids and muscle loss. Nausea, diarrhea, taste changes, poor appetite and unintentional weight loss can all make fatigue worse. Dietitian input and symptom control may matter more than an energy product.
- Sleep, pain and medications. Insomnia, sleep apnea, uncontrolled pain, sedating drugs and some treatment-related symptoms may be modifiable.
- Emotional and cognitive burden. Anxiety, depression and ongoing stress can coexist with physical contributors. They deserve assessment without dismissing the fatigue as “just psychological.”
- Treatment-specific complications. Some cancer treatments can cause additional medical problems. In people receiving immune-checkpoint inhibitors, thyroid or adrenal dysfunction, or inflammation of the pituitary, can present with pronounced fatigue; dizziness, vomiting, headache or other new symptoms may make assessment urgent.
The NCI’s patient guide reviews common contributors. The ASCO immune-related adverse-events guideline discusses endocrine complications of immunotherapy. The right evaluation depends on treatment context; patients should not attempt to diagnose these conditions themselves.
What has evidence for improving fatigue?
Movement that fits the person
Guidelines strongly support individualized aerobic activity, resistance training or both during and after cancer treatment. This does not mean pushing through severe symptoms. A short walk, chair-based movement or supervised cancer rehabilitation may be a reasonable starting point after the care team checks safety—especially with bone metastases, significant anemia, falls, heart or lung symptoms, or neuropathy.
CBT and mindfulness-based programs
CBT can help identify and change patterns of activity, sleep and coping that amplify fatigue; it is not a claim that fatigue is imagined. Structured mindfulness programs can help people manage fatigue and distress. The guideline supports both approaches during and after treatment, including some remotely delivered programs.
Other approaches depend on treatment stage
Tai chi and qigong have guideline support during active treatment; yoga or acupressure may be considered after treatment. Access, mobility, preferences and the quality of the specific program matter. Results in research groups do not predict exactly how an individual will feel.
What about supplements?
The evidence is not uniformly negative, but neither does a supplement label make a product effective. In a multicenter, placebo-controlled randomized trial involving 364 enrolled patients, American ginseng (Panax quinquefolius), 2,000 mg/day for eight weeks improved a fatigue score more than placebo at week eight, although the difference at the trial’s primary four-week endpoint was not statistically significant. The 2024 ASCO–SIO guideline says clinicians may recommend American ginseng during active cancer treatment, a conditional recommendation based on low-certainty evidence; it does not make the same recommendation for survivors after completing treatment.
That nuance matters: one positive trial does not establish the best formulation, safety in every cancer-treatment regimen or benefit from every commercial product. Other dietary supplements generally have not demonstrated consistent improvements in cancer-related fatigue in guideline-reviewed trials. Patients should review any product and medication list with their oncology team for interactions, quality concerns and situations in which it may be unsuitable. Do not delay investigation of a new cause of fatigue in order to try a supplement.
When fatigue needs more urgent attention
Contact the oncology team promptly for new or rapidly worsening fatigue, fever or chills, inability to keep fluids down, marked dizziness, or pronounced weakness—particularly during chemotherapy or immunotherapy. Fever during chemotherapy can signal a serious infection even when other symptoms seem mild (CDC guidance).
Seek emergency evaluation for chest pain, severe or sudden difficulty breathing, fainting, new confusion or inability to remain awake. Do not assume these are ordinary cancer fatigue.
Questions to bring to a visit
- What changed in my treatment, medications, sleep, appetite or activity around the time the fatigue began?
- Could anemia, dehydration, infection, endocrine problems or another condition explain part of it?
- What level of activity is safe, and would an oncology rehabilitation or exercise specialist help?
- Could a fatigue-focused CBT or mindfulness program be useful?
- If I am considering a supplement, what evidence applies to my situation and what interactions should we check?
- What improvement would be meaningful to track, and when should we reassess?
The bottom line
Cancer fatigue deserves both investigation and support. Look for treatable contributors, use interventions with human evidence, and measure progress in terms that matter—perhaps having the energy to cook, walk or enjoy time with family. The goal is not to make people push harder; it is to make the care plan more precise.
Key sources
- Bower JE et al. ASCO–SIO guideline update on cancer-related fatigue. Journal of Clinical Oncology, 2024. Review and recommendations based on 113 randomized trials.
- NCI. Fatigue (PDQ®), health professional version. Causes, assessment and evidence context.
- NCI. Cancer Fatigue, patient version. Practical overview.
- Barton DL et al. Wisconsin ginseng and cancer-related fatigue (N07C2). JNCI, 2013. Randomized placebo-controlled trial.
- Schneider BJ et al. Management of immune-related adverse events: ASCO guideline update. JCO, 2021. Endocrine safety context.
- CDC. Know the signs and symptoms of infection during cancer treatment. Reviewed November 2024.
Further reading: Evidence Explorer: Symptoms & Supportive Care · Neuropathy safety during treatment · How to evaluate evidence.
Educational information only. This article does not replace advice from your oncology team and is not a recommendation to start, stop or change any treatment or supplement. Evidence and guideline recommendations depend on clinical context. Reviewed November 11, 2026.